Literature DB >> 179826

A noradren aline sensitive adenylate cyclase in the rat limbic forebrain: preparation, properties and the effects of agonists, adrenolytics and neuroleptic drugs.

A S Horn, O T Phillipson.   

Abstract

A method for the preparation of a noradrenaline sensitive adenylate cyclase from homogenates of the rat 'limbic' forebrain is described using Krebs--Ringer as the homogenising medium. Some of its properties resemble those reported previously by other workers, using slices. Its response to agonists show that it has the characteristics of a beta1-receptor i.e. the potency of 1-isoprenaline exceeds that of 1-noradrenaline which exceeds that of 1-adrenaline. Structure--activity analysis of the response of the adenylate cyclase to a range of adrenergic agonists shows a strict requirement for a catechol moiety and a beta-hydroxyl group. The activation of the enzyme by 1-noradrenaline is sensitive to stereoselective inhibition by 1-propranolol. The effect of a number of neuroleptic drugs was examined. Promazine was the most effective agent tested in antagonising the stimulation produced by 50 muM 1-noradrenaline, whilst the potent dopamine receptor antagonist, alpha-flupenthixol was only weakly active. Furthermore, there was no stereoselectivity in the antagonism produced by alpha- and beta-siomers of flupenthixol. Pimozide was not found to be a potent antagonist. Thus the spectrum of antagonism produced by neuroleptic drugs was quite different from that seen in the dopamine sensitive adenylate cyclase of the rat corpus striatum.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 179826     DOI: 10.1016/0014-2999(76)90002-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  Rapid isolation of synaptoneurosomes and postsynaptic densities from adult mouse hippocampus.

Authors:  Laura Elena Villasana; Eric Klann; Maria Victoria Tejada-Simon
Journal:  J Neurosci Methods       Date:  2006-06-23       Impact factor: 2.390

2.  Structural and steric requirements for beta-phenethylamines as agonists of the noradrenergic cyclic AMP generating system in the rat limbic forebrain.

Authors:  S E Robinson; P L Mobley; H E Smith; F Sulser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-06       Impact factor: 3.000

3.  Behavioural and biochemical effects of chronic reduction of cerebral noradrenaline receptor stimulation.

Authors:  A Dolphin; M Christina; M C Sawaya; P Jenner; C D Marsden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-09       Impact factor: 3.000

4.  Alpha-receptor-mediated modulation of 3H-noradrenaline release from rat brain cortex synaptosomes.

Authors:  A H Mulder; C D de Langen; V de Regt; F Hogenboom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-06       Impact factor: 3.000

5.  Pharmacological interactions with circling behaviour induced by the piperidinyl indole derivative RU 23686.

Authors:  J R Boissier; C Oberlander; C Dumont; M Peterfalvi
Journal:  Psychopharmacology (Berl)       Date:  1977-11-24       Impact factor: 4.530

6.  Transmembrane flux and receptor desensitization measured with membrane vesicles. Homogeneity of vesicles investigated by computer simulation.

Authors:  D J Cash; R M Langer; K Subbarao; J R Bradbury
Journal:  Biophys J       Date:  1988-11       Impact factor: 4.033

7.  Central levels of noradrenaline, 3-methoxy-4-hydroxyphenylethyleneglycol and cyclic AMP in the rat after activation of locus coeruleus neurons: influence of single and repeated neuroleptic treatment.

Authors:  J P Adèr; J B Sebens; J Korf
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

8.  Characteristics of chick cerebral beta-adrenoceptors assessed by cyclic adenosine 3',5' monophosphate formation and [3H]-propranolol binding.

Authors:  S R Nahorski; B M Smith
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-05       Impact factor: 3.000

9.  Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram.

Authors:  J Hyttel; K F Overø; J Arnt
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram.

Authors:  J Arnt; K F Overø; J Hyttel; R Olsen
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.